NATION, R.L. (1982) . Diazepam (Weiner, 1980) . On the other hand, it is also known that locally administered noradrenaline can attenuate the rise in muscle blood flow due to exercise (Berstein & White, 1974) . The purpose of the present study was to evaluate the effect of the a-adrenoceptor blocking drug dihydroergocryptine mesylate on resting blood flow and reactive hyperaemia in nonnal volunteers. Dihydroergocryptine is one of the components of dihydroergotoxine, the others being dihydroergocomine and dihydroergocristine (Rutschmann & Stadler, 1978 Muscle flow was determined according to the method of Lassen et al. (1964) , by the clearance of xenon '33 Approximately 200 ,uCi xenon' 33 dissolved in 0.2 ml of 0.9% saline was injected via a small needle (0.25 mm in external diameter and 15 mm in length) into the upper part of the left tibialis anterior muscle and the clearance of radioactivity was followed by means of a scintillation counter with a thallium activated sodium iodide crystal. The crystal was placed at a distance of 6 cm from the skin and was shielded by a lead collimator with a cylindrical bore of 22 mm diameter. By this means an initial count rate of over 3,000 counts/s was achieved. A rate meter time constant of 3 s was employed. Blood flow measurements were recorded on each occasion after the subject had been lying for at least 15 min. The first 5 min period post-injection was discarded. The calculation of blood flow was carried out after the method of Alpert et al. (1966) , as adapted by Corman and associates (1970) .
The muscle blood flow partition for xenon was assumed to be 0.7.
The effect of combined cuff occlusion and plantar and dorsi flexion was also assessed. The cuff was placed around the lower thigh and inflated to 180 mm Hg for 150 s. During the ischaemic period the subjects were asked to plantar and dorsi flex their foot 80 times. The maximum flow increase was calculated over the minute period immediately following deflation.
Two sets of measurements were obtained from each subject in all. Each was obtained at the end of 1 week's treatment with either drug or placebo, 3-4 h after the last dosage. Five subjects were given active compound first, and five were given placebo. This was randomised in the conventional way.
Subjects were asked to withdraw 4 ml of a clear fluid from a small bottle into a syringe and then to pour this into a glass of water. Medication was taken immediately after breakfast and after the evening meal. 1 ml of the solution contained 1 mg of dihydroergocryptine mesylate and 10 mg of caffeine, or placebo.
The results are shown in Table 1 . One should be cautious about the interpretation of individual results on two separate occasions as sampling error may cause some variation in baseline values and in hyperaemic response. No significant difference in mean resting muscle blood flow was noted between placebo and active treatments, although there was a tendency for flow to be higher on drug. However, dihydroergocryptine produced an appreciable overall increase in the flow during the reactive hyperaemia period compared to that of placebo treatment (twotailed test, t = 2.93, P < 0.02). One subject complained of an occasional headache lasting 1-2 h after taking the active preparation.
Since there is said to be little sympathetic tone at rest, the fact that dihydroergocryptine had no appreciable effect on resting muscle blood flow should occasion no surprise. However, the effect of dihydroergocryprine after occlusion and exercise is not so easily explained. It has generally been held that hyperaemia after exercise or after simple venous occlusion is not affected by the rate of sympathetic discharge (Folkow & Neil, 1971) . On the other hand, as mentioned earlier, locally administered noradrenaline can attenuate the rise via muscle blood flow due to exercise (Berstein & White, 1974 
